Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer

Khine Kyaw Oo(Siriraj Hospital), Peti Thuwajit(Siriraj Hospital)
BMC Cancer
January 14, 2021
Cited by 47


Related Papers